MENU

Can Schwab U.S. Dividend Equity ETF (SCHD) Reach $40?

Category: #Large Value
SCHD
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days
A.I.Advisor
Aug 22, 2026

Can Schwab U.S. Dividend Equity ETF (SCHD) Reach $40?

Key Takeaways

  • The Schwab U.S. Dividend Equity ETF (SCHD) recently traded near $34, making a $40 price target roughly 17% above current levels.
  • The strongest bullish case rests on a sustained rotation into value and dividend-paying equities, record asset inflows, and defensive exposure to healthcare and consumer staples.
  • The biggest obstacles are elevated Treasury yields, signs that quarterly dividend growth has slowed, and a modest consensus analyst outlook.
  • Key levels include the prior breakout zone near $32 and the 52-week high around $34.50, which is the immediate resistance before $40 can be tested.
  • The $40 level is a realistic but multi-year objective that likely requires continued macro tailwinds rather than a short-term catalyst.

Why Investors Are Watching the $40 Level

The $40 mark has become a focal point in public market discussion around SCHD. After the fund rallied sharply through 2026, several technical analysts and commentary have pointed toward $40 as the next psychologically significant milestone, with the level appearing in published research as a potential year-end objective. Because $40 sits roughly 17% above the fund's recent trading range, it represents a meaningful but not implausible extension of the current trend rather than an already-reached or out-of-reach figure.

ETF Overview and Current Market Position

SCHD is one of the largest dividend-focused exchange-traded funds (ETFs) in the United States, holding more than $100 billion in assets. It tracks the Dow Jones U.S. Dividend 100 Index, a rules-based basket of roughly 100 U.S. companies screened for dividend sustainability and quality, and carries a low expense ratio of 0.06%. The fund has outperformed the broader market in 2026, gaining around 19% year to date and more than 25% over the trailing 12 months as investors rotated out of richly valued growth and technology names into defensive, cash-generating businesses.

At recent levels near $34, SCHD sits just below its 52-week high of about $34.50. Its portfolio is concentrated in healthcare, consumer staples, and energy, with top holdings including Abbott Laboratories (ABT), Amgen (AMGN), Merck (MRK), UnitedHealth Group (UNH), Coca-Cola (KO), and Chevron (CVX). The top ten positions account for roughly 40% of the portfolio, meaning the performance of a handful of large names can meaningfully influence the fund.

What Could Drive SCHD Toward $40

The core argument for further upside is the ongoing shift from growth into value and income. If long-term Treasury yields ease and the Federal Reserve refrains from additional rate increases, the relative appeal of a dividend yield around 3% improves, historically supporting dividend equities. A softer labor market and easing inflation data have reduced near-term rate-hike fears, a development that several analysts cite as a tailwind for the fund.

Fund flows reinforce the thesis. SCHD has absorbed billions of dollars in net inflows during 2026 as investors sought defensive hedges against elevated technology valuations. Continued demand for income-producing exposure, combined with gradual earnings and dividend growth from its largest holdings, could provide the steady appreciation needed to push the fund toward $40 over a multi-year horizon.

What Could Prevent the Move

The most significant risk is the level of long-term interest rates. When investors can earn roughly 4% or more in risk-free Treasuries, the bar for owning equity income rises, and dividend-paying stocks become less attractive on a relative basis. A sustained move in the 10-year Treasury yield above recent ranges would likely pressure SCHD's valuation, echoing the rate-driven selloff in dividend equities seen in 2022.

A second concern is dividend growth itself. Recent quarterly distributions have shown signs of deceleration, with some payouts printing slightly below prior-year comparables. Because SCHD's reputation rests on a track record of rising payouts, a stalled dividend-growth narrative could weaken the case for further multiple expansion. A sharper economic slowdown that triggers earnings weakness or dividend cuts among its large holdings would also undermine the fund's path higher.

Technical Levels and Analyst Targets

From a technical perspective, the prior breakout area near $32 now functions as a support level, while the 52-week high around $34.50 represents immediate resistance. Clearing that high is a prerequisite before the psychological $40 level can realistically be tested. A retreat toward the $32–$33 range would not invalidate the longer-term uptrend, but would signal that the rally needs a fresh catalyst.

It is worth noting that consensus analyst price targets, derived by aggregating forecasts for the fund's underlying holdings, are more conservative than the $40 objective, clustering near the current price around $34. This divergence underscores that $40 is best viewed as a technical and rotation-driven scenario rather than a level embedded in mainstream analyst forecasts.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals provide an additional tool for investors tracking ETFs like SCHD. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify shifting market trends more efficiently. For those watching whether SCHD can build toward $40, automated signal monitoring can help flag changes in trend and momentum without requiring constant manual chart review.

Final Assessment

The $40 price target for SCHD appears achievable over a longer horizon, but it is not a near-term certainty. The strongest supports are the rotation into value and income, substantial fund inflows, and a defensive portfolio that has outperformed the broader market. The primary risks are persistently elevated Treasury yields, slowing dividend growth, and the possibility that the current momentum stalls at the 52-week high. Investors weighing this target should monitor long-term interest rates, quarterly distribution trends, and whether the fund can hold above its breakout zone near $32 while challenging resistance around $34.50.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
SCHD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SCHD and ETFs

Correlation & Price change

A.I.dvisor indicates that over the last year, SCHD has been closely correlated with FTA. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCHD jumps, then FTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCHD
1D Price
Change %
SCHD100%
-0.03%
FTA - SCHD
94%
Closely correlated
-0.77%
FVD - SCHD
91%
Closely correlated
-0.61%
DVY - SCHD
91%
Closely correlated
-0.79%
SNPD - SCHD
91%
Closely correlated
N/A
KNG - SCHD
89%
Closely correlated
-0.74%
More